Ubs Group Ag Athira Pharma, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 11,828 shares of ATHA stock, worth $6,268. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,828

Previous 932 1169.1%

Holding current value

$6,268

Previous $2,000 150.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.42 - $3.43 $4,576 - $37,373	10,896 Added 1169.1%	11,828 $5,000
Q4 2023 Feb 09, 2024	SELL	$1.39 - $2.46 $137,012 - $242,482	-98,570 Reduced 99.06%	932 $2,000
Q3 2023 Nov 09, 2023	BUY	$1.9 - $3.16 $135,291 - $225,010	71,206 Added 251.65%	99,502 $200,000
Q2 2023 Aug 11, 2023	BUY	$2.36 - $3.59 $11,349 - $17,264	4,809 Added 20.48%	28,296 $83,000
Q1 2023 May 12, 2023	SELL	$2.26 - $4.22 $179,346 - $334,886	-79,357 Reduced 77.16%	23,487 $58,000
Q4 2022 Feb 08, 2023	BUY	$2.76 - $3.71 $104,112 - $139,948	37,722 Added 57.93%	102,844 $326,000
Q3 2022 Nov 10, 2022	BUY	$2.93 - $3.96 $24,280 - $32,816	8,287 Added 14.58%	65,122 $193,000
Q2 2022 Aug 10, 2022	BUY	$2.74 - $13.43 $1,424 - $6,983	520 Added 0.92%	56,835 $173,000
Q1 2022 May 16, 2022	BUY	$8.96 - $13.51 $386,355 - $582,551	43,120 Added 326.79%	56,315 $760,000
Q4 2021 Feb 14, 2022	SELL	$9.17 - $16.39 $508,925 - $909,628	-55,499 Reduced 80.79%	13,195 $172,000
Q3 2021 Nov 15, 2021	BUY	$9.15 - $11.09 $617,021 - $747,843	67,434 Added 5351.9%	68,694 $644,000
Q2 2021 Aug 13, 2021	BUY	$10.24 - $20.87 $5,734 - $11,687	560 Added 80.0%	1,260 $13,000
Q1 2021 May 12, 2021	SELL	$16.9 - $29.77 $2.76 Million - $4.86 Million	-163,152 Reduced 99.57%	700 $13,000
Q4 2020 Feb 11, 2021	BUY	$16.48 - $34.3 $2.29 Million - $4.76 Million	138,883 Added 556.22%	163,852 $5.61 Million
Q3 2020 Nov 12, 2020	BUY	$16.02 - $18.46 $400,003 - $460,927	24,969 New	24,969 $461,000

Others Institutions Holding ATHA

# of Institutions

Shares Held

16.9M

Call Options Held

112K

Put Options Held

68K

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $20M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account